-

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins Scientific SE (Paris:ERF):

ANNEXE B

Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities

  1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF
    EUROFINS SCIENTIFIC SE – E1013
  2. Identity of the notifier (if another person makes the notification on behalf of the issuer) N/A
  3. Total number of shares composing the share capital of the notifying issuer
    182,163,000
  4. Total number of voting rights attached to the shares composing the share capital of the notifying issuer, including the suspended voting rightsii
    366,664,553
  5. Origin of the changeiii
    • Cancellation of some class A beneficiary units
    • Purchase of treasury shares
  6. Date when the change occurred
    30 November 2025

i Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.
ii For further details on the total number of voting rights, please refer to point 1(b) of circular CSSF 08/349.
iii As, for example, a capital increase or reduction.

Contacts

Eurofins Scientific SE

Eurofins Scientific SE

BOURSE:ERF

Release Versions

Contacts

Eurofins Scientific SE

More News From Eurofins Scientific SE

Eurofins Medical Device Services Launches first GMP PFAS Screening and Testing Solutions for Medical Devices

LANCASTER, Pa.--(BUSINESS WIRE)--Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launched a GMP PFAS testing and screening solution, the first developed and commercialized for the medical device industry. This offering provides insights to medical device manufacturers as they navigate the complex and evolving global regulations surrounding PFAS, ultimately contributin...

Eurofins: Weekly Report on Share Repurchases From 24th November to 28th November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 24/11/2025 FR0014000MR3 20 000 58.4487 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/11/2025 FR0014000MR3 20 000 58.6804 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/1...

Eurofins: Weekly Report on Share Repurchases From 17th November to 21st November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 17/11/2025 FR0014000MR3 20 000 58.7743 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 18/11/2025 FR0014000MR3 20 000 57.7048 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 19/1...
Back to Newsroom